People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

10:53pm IST
Change (% chg)

$0.68 (+0.89%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Heron, Elaine 

Dr. Elaine J. Heron, Ph.D., is an Independent Director of Biomarin Pharmaceutical Inc. Dr. Heron joined our Board in July 2002 and serves as the Chair of the Corporate Governance and Nominating Committee. Dr. Heron served as Chair and Chief Executive Officer of Amplyx Pharmaceuticals, Inc., a private early stage drug development company, from February 2009 until October 2015, and she continues to serve as member of that company’s board. She is also a member of the boards of directors of Valla Sciences, Inc, a private life science tools company, and Palvella Therapeutics, a private early stage therapeutics company. From July 2001 to October 2008, Dr. Heron was Chair and Chief Executive Officer of Labcyte Inc., a private biotechnology company. Before joining Labcyte Inc., she spent six years in positions of increasing responsibility at the Applied Biosystems Group of Applera Corporation, a biotechnology company, including the position of General Manager and Vice President of Sales and Marketing. Dr. Heron earned a B.S. in chemistry with highest distinction and a Ph.D. in analytical biochemistry from Purdue University and an M.B.A. from Pepperdine University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 183,680
Long-Term Incentive Plans, USD --
All Other, USD 282,590
Fiscal Year Total, USD 466,270

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jean-Jacques Bienaime


Daniel Spiegelman


Henry Fuchs


G. Eric Davis


Jeff Ajer


Robert Baffi

As Of  31 Dec 2017